SCHEMBL8879370

SCHEMBL8879370

O=C1CC=CC2=C1c1ccc(C(F)(F)F)cc1SN=C2

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TDP2 O95551 1/20 0.32
▸ PTPN5 P54829 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8880019 0.80 KDM4E (0.32) —
SCHEMBL8880090 0.76 ATM (0.31) TDP2
SCHEMBL8879507 0.75 MEN1 (0.35) —
SCHEMBL8880983 0.74 PSMB8 (0.31) —
SCHEMBL8880270 0.73 PTPN5 (0.31) PTPN5
SCHEMBL8880767 0.69 — —
SCHEMBL8880391 0.69 — —
SCHEMBL9007426 0.68 — —
SCHEMBL9007286 0.65 POLB (0.32) —
SCHEMBL8880832 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607929-A Antiviral dibenzothiazepinone derivatives GLAXO WELLCOME INC. (US) 1997-03-04 — — US claimed
EP-0583288-A1 ANTIVIZAL DIBENZOTHIAZEPINONE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-23 — — EP claimed
WO-1992019277-A1 ANTIVIRAL DIBENZOTHIAZEPINONE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1992-11-12 — — WO claimed
US-5607929-A Antiviral dibenzothiazepinone derivatives GLAXO WELLCOME INC. (US) 1997-03-04 — — US disclosed
EP-0583288-A1 ANTIVIZAL DIBENZOTHIAZEPINONE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-23 — — EP disclosed
WO-1992019277-A1 ANTIVIRAL DIBENZOTHIAZEPINONE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1992-11-12 — — WO disclosed
Send feedback